SCHEMBL9542879

SCHEMBL9542879

C#CC1(c2ccccc2)c2ccccc2NC(=O)N1C

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 9/20 0.46
LMNA P02545 1/20 0.42
PDK2 Q15119 1/20 0.38
PDK4 Q16654 1/20 0.38
PKM P14618 1/20 0.37
BRD4 O60885 2/20 0.36
CREBBP Q92793 1/20 0.35
GAA P10253 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
MGAM O43451 1/20 0.34
SI P14410 1/20 0.34
MGAM2 Q2M2H8 1/20 0.34
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9540147 0.84 BRD4 (0.37) AKR1B1PKMBRD4
SCHEMBL9539078 0.84 AKR1B1 (0.48) AKR1B1PKMBRD4MAPTKMT2A
SCHEMBL9539767 0.84 AKR1B1 (0.48) AKR1B1BRD4GAAMAPTKMT2A
SCHEMBL9539832 0.81 AKR1B1 (0.51) AKR1B1LMNABRD4ALDH1A1MAPT
SCHEMBL16108835 0.74 BRD4 (0.53) AKR1B1LMNAPDK2PDK4PKM
SCHEMBL9571265 0.71 AKR1B1 (0.47) AKR1B1LMNAPDK2PDK4PKM
SCHEMBL9540059 0.69 PGR (0.40) AKR1B1MAPT
SCHEMBL9542678 0.68 AKR1B1 (0.38) AKR1B1GAAMAPTKMT2AMGAM
SCHEMBL27371367 0.68 ALDH1A1 (0.30) LMNAGAAALDH1A1
SCHEMBL9539751 0.67 AKR1B1 (0.38) AKR1B1GAAMAPTKMT2AMGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0530994-A1 Quinazoline derivatives as inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1993-03-10 EP disclosed
WO-1993004047-A1 QUINAZOLINE DERIVATIVES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE MERCK & CO., INC. (US) 1993-03-04 WO disclosed